Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06263621 · ClinicalTrials.gov registry record · NA

Changing Portion Size Descriptions in a Cafeteria

A NA study, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
101,481
Enrollment target

NCT06263621: Completed NA study, sponsored by University of Pennsylvania.

NCT06263621 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 101,481 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (7138% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06263621, a NA study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
101,481 participants
Enrollment target

Study Summary

The goal of this this intervention is to test the degree to which a portion size labeling intervention influences consumer selection of smaller portions at two large cafés. The main question it aims to answer is: Do consumers order fewer calories when the portion size label for the smaller entree is called "standard" instead of "small"? Participants will order lunch as usual in the two cafes (one intervention, one control) for 5.5 months, and all order items will be recorded in the check-out system. One cafe will receive the labeling intervention, while the other will not. Researchers will compare the average calories per order between the two cafes to see if there are differences.

Primary Outcome

The primary outcome will be the average kcal per entrée purchased.

Interventions

  • BEHAVIORAL Intervention "Standard"

Trial Details

FieldValue
Enrollment Target 101,481 participants
Start Date 2024-01-11
Est. Completion 2024-05-29
Phase NA
University of Pennsylvania

1,423 total trials

What the finished NCT06263621 record still lists

NCT06263621 is an interventional study that assigns participants to a tested intervention. Its 101,481 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (7138% higher).

The record links to 0 conditions, and to 1 intervention - of which Intervention "Standard" is the first listed.

NCT06263621 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06263621 about?

NCT06263621 is a clinical study titled "Changing Portion Size Descriptions in a Cafeteria". The goal of this this intervention is to test the degree to which a portion size labeling intervention influences consumer selection of smaller portions at two large cafés. The main question it aims to answer is: Do consumers order fewer calories when the portion size label for the smaller entree is...

What is the current status of trial NCT06263621?

This trial is currently completed. It is a NA study. The enrollment target is 101,481 participants. The study started on 2024-01-11. Estimated completion is 2024-05-29.

What interventions are being tested in trial NCT06263621?

The interventions under investigation include: Intervention "Standard" (BEHAVIORAL).

Who is sponsoring clinical trial NCT06263621?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06263621's enrollment target sits among peer trials

101,481 3rd of 2000 higher than 1,998 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02917460 · 102,000 participants · NA

    Rady Children's Institute Genomic Biorepository

  • NCT05741112 · 100,500 participants · NA

    The Long COVID-19 Wearable Device Study

  • NCT02620852 · 100,000 participants · NA

    Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

  • NCT03277365 · 100,000 participants · NA

    MyGeneRank: A Digital Platform for Next-Generation Genetic Studies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06263621, the US trial registry maintained by the National Library of Medicine. NCT06263621 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.